We have previously analysed the bioenergetic consequences of activating J774.A1 macrophages (MU) with interferon-c (IFN-c) and lipopolysaccharide (LPS) and found that there is a nitric oxide (NO)-dependent mitochondrial impairment and stabilization of hypoxia-inducible factor (HIF)-1a, which synergize to activate glycolysis and generate large quantities of ATP. We now show, using tetramethylrhodamine methyl ester (TMRM) fluorescence and time-lapse confocal microscopy, that these cells maintain a high mitochondrial membrane potential (DW m ) despite the complete inhibition of respiration. The maintenance of high DW m is due to the use of a significant proportion of glycolytically generated ATP as a defence mechanism against cell death. This is achieved by the reverse functioning of F o F 1 -ATP synthase and adenine nucleotide translocase (ANT). Treatment of activated MU with inhibitors of either of these enzymes, but not with inhibitors of the respiratory chain complexes I to IV, led to a collapse in DW m and to an immediate increase in intracellular [ATP], due to the prevention of ATP hydrolysis by the F o F 1 -ATP synthase. This collapse in DW m was followed by translocation of Bax from cytosol to the mitochondria, release of cytochrome c into the cytosol, activation of caspases 3 and 9 and subsequent apoptotic cell death. Our results indicate that during inflammatory activation 'glycolytically competent cells' such as MU use significant amounts of the glycolytically generated ATP to maintain DW m and thereby prevent apoptosis. Activation of murine macrophages (MF) with interferon-g (IFN-g) and lipopolysaccharide (LPS) leads to a mitochondrial defect that is dependent on the release of large quantities of nitric oxide (NO) produced by the inducible NO synthase (iNOS). This NO-dependent mitochondrial defect results in the complete arrest of mitochondrial ATP synthesis by oxidative phosphorylation (OXPHOS). In this situation, macrophages upregulate glycolysis by several fold to generate more ATP. In spite of this increase, the demand for energy of activated MF is such that the cellular [ATP] is reduced by approximately 40% after 12 h. However, at this time there is no difference in the viability of control and activated MF. 1 We have previously shown in Jurkat cells that after inhibition of respiration by exogenous NO, or by endogenous NO generated after treatment with anti-Fas antibody, there is upregulation of glycolysis and hyperpolarization of the mitochondrial membrane potential (DC m ). 2, 3 In subsequent experiments we showed that such hyperpolarization occurs only in cells capable of upregulating glycolysis, such as astrocytes, but not in neurons that are unable to do so. 4 In the latter cells there is a rapid and progressive decline of DC m and increased apoptotic cell death. It is known that the onset of apoptosis is associated with a collapse in DC m and an alteration in mitochondrial matrix configuration, [5] [6] [7] leading to the release of pro-apoptotic proteins into the cytosol. [8] [9] [10] [11] [12] 
Activation of murine macrophages (MF) with interferon-g (IFN-g) and lipopolysaccharide (LPS) leads to a mitochondrial defect that is dependent on the release of large quantities of nitric oxide (NO) produced by the inducible NO synthase (iNOS). This NO-dependent mitochondrial defect results in the complete arrest of mitochondrial ATP synthesis by oxidative phosphorylation (OXPHOS). In this situation, macrophages upregulate glycolysis by several fold to generate more ATP. In spite of this increase, the demand for energy of activated MF is such that the cellular [ATP] is reduced by approximately 40% after 12 h. However, at this time there is no difference in the viability of control and activated MF. 1 We have previously shown in Jurkat cells that after inhibition of respiration by exogenous NO, or by endogenous NO generated after treatment with anti-Fas antibody, there is upregulation of glycolysis and hyperpolarization of the mitochondrial membrane potential (DC m ). 2, 3 In subsequent experiments we showed that such hyperpolarization occurs only in cells capable of upregulating glycolysis, such as astrocytes, but not in neurons that are unable to do so. 4 In the latter cells there is a rapid and progressive decline of DC m and increased apoptotic cell death. It is known that the onset of apoptosis is associated with a collapse in DC m and an alteration in mitochondrial matrix configuration, [5] [6] [7] leading to the release of pro-apoptotic proteins into the cytosol. [8] [9] [10] [11] [12] Mitochondrial membrane hyperpolarization has been observed in cells of the immune system in which apoptosis has been induced by a variety of agents, including withdrawal of growth factor, 13 Fas signalling, 2,3,14 hypoxia, 15 T-cell activation 16, 17 and staurosporine treatment. 18 Increases in DC m were not observed, however, when other apoptosis-inducing agents, such as permeabilization of the outer mitochondrial membrane, 5, 19 H 2 O 2 20 and dexamethasone, [21] [22] [23] were used. Thus it is possible that mitochondrial membrane hyperpolarization is part of a defence mechanism, which precedes apoptosis, developed by glycolytically competent cells provided that the mitochondria are not the primary target of the apoptosis-inducing agent. Such might be the case in activated lymphocytes from patients with systemic lupus erythematosus that have hyperpolarized mitochondria and are resistant to apoptosis. 24 In such a situation, apoptosis would follow the failure of the cells to maintain DC m .
To analyse whether the fate of cells is critically dependent on the regulation of the mitochondrial status, especially DC m , we decided to study the sequence of events that follows the increase, and later collapse, of DC m in J774.A1 MF activated for a period longer than the 12 h used previously. 1 In this study we show that activated MF use significant amounts of glycolytically generated ATP to maintain the DC m of defective mitochondria that are unable to generate ATP. This is achieved through F o F 1 -ATP synthase and adenine nucleotide translocase (ANT) acting in reverse mode. Disruption of such a mechanism by inhibiting either of these enzymes leads to a collapse in DC m , translocation of the pro-apoptotic Bcl-2 protein Bax to the mitochondria, release of cytochrome c into the cytosol, subsequent activation of pro-apoptotic caspases and apoptotic cell death.
Results
Effect of activation of MU on their DW m . Mitochondrial oxygen uptake (respiration) of IFN-g and LPS-treated (activated) MF was almost completely (X95%) inhibited within the first 12 h (not shown), an effect that was maintained throughout the experimental period of 72 h (Figure 1a) . To distinguish the NO-dependent and NO-independent components of inflammation, some activated macrophages were treated with the NO synthase inhibitor, S-ethyl isothiourea (SEITU; 500 mM), at the time of activation. In activated þ SEITU-treated MF, respiration was higher than in controls (62.3 ± 6.6 versus 51.4 ± 2.5 pmol O 2 /s/10 6 cells), but in both groups it could be reduced by approximately 70% after treatment with oligomycin, indicating that the mitochondria are coupled to the same extent (Figure 1a) . Furthermore, treatment with p-trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP) led to a maximal respiration rate that was similar in both groups (104 ± 6.8 versus 97.6 ± 7.2 pmol O 2 /s/10 6 cells for control and for activated þ SEITU-treated cells, respectively).
Despite the total inhibition of respiration, the DC m of activated MF, measured by tetramethyl rhodamine methyl ester (TMRM) fluorescence, was significantly increased from 742±75 a.u. (of controls) to 910±69 a.u. (Figures 1b and c) . MF, whose respiration is completely inhibited by NO, points to the involvement of the reverse function of F o F 1 -ATP synthase. The DC m of activated þ SEITU-treated MF was also significantly higher than that of controls (1095 ± 85 a.u.; Figure 1d ).
Dependence of DW m on F o F 1 -ATP synthase in activated MU. Three treatment groups of cells (control, activated, and activated plus SEITU-treated) were incubated for 72 h and then treated with oligomycin (2 mg/ml) or bongkrekic acid (10 mM) to inhibit F o F 1 -ATP synthase or ANT, respectively, while recording DC m using time-lapse confocal microscopy. Treatment with either compound led to a rapid and significant increase in DC m in the control and in the activated þ SEITUtreated MF (Figures 2a and b) . This effect was maintained for at least 12 h (not shown). In contrast, treatment of activated MF with either compound led to an immediate fall in DC m to approximately 70% (Figures 2a and b) . This was followed by a progressive decline to approximately 39±5% within the next 60 min and to 15±4% of the original values within 24 h (not shown). The effect of oligomycin and bongkrekic acid on the DC m of activated MF could be observed from 12 h activation onwards, when respiration was almost completely (495%) inhibited. The TMRM fluorescence in all cell groups could be abolished by treatment with FCCP, indicating its specificity to DC m (Figures 2a and b) . We also used aurovertin B and atractyloside to inhibit F o F 1 -ATP synthase and ANT, respectively, and found that they gave similar results as oligomycin and bongkrekic acid (not shown).
In a separate group of experiments the three groups of cells were treated with antimycin A, rotenone or KCN. These respiratory chain inhibitors did not affect the DC m of activated MF but significantly reduced that of both control and of activated þ SEITU-treated groups (see Figure 2c Figure 3a) . After a further 12 h, however, the [ATP] was restored to a value of 9.6 ± 0.84 nmol ATP/10 6 cells (Figure 3b ). This was associated with upregulation of glycolysis, as showed by lactate accumulation in the medium during this period (Figure 3c DW m and cell viability. Three treatment groups of cells (control, activated, and activated plus SEITU-treated) were incubated for 12 h before treatment with oligomycin, bongkrekic acid or antimycin A. Control MF had a viability of X98% throughout the experimental period and treatment with oligomycin or bongkrekic acid had no significant effect on cell viability ( Figure 4a ). Activation of MF reduced viability to approximately 64% within 72 h. Treatment of activated MF with oligomycin reduced the viability to 35% by 48 h and to 0% by 72 h (Figure 4a ). Activated þ SEITU-treated MF had a viability of approximately 86% at 72 h. Oligomycin treatment reduced the viability of these MF to 12% by 48 h and to 0% by 72 h (Figure 4a ). The effects of bongkrekic acid treatment were similar to those of oligomycin in all treatment groups (not shown). Antimycin A treatment of activated þ SEITU-treated MF reduced the viability to 10% by 48 h and 0% by 72 h but had no effect on the viability of activated MF (Figure 4b) .
To assess the extent of dependence of activated MF on glycolytically generated ATP for survival, we switched to a medium in which galactose was the sole source of carbohydrate, after 12 h activation. The conversion of galactose to pyruvate does not yield net glycolytic ATP; thus, cells need functional mitochondria to survive in such a medium. The viability of control MF was not affected by replacement of glucose in the medium with galactose. In contrast, such treatment led to cell death (498%) of activated MF within 8 h, whereas incubation of activated þ SEITU-treated MF in this medium led to a gradual reduction of viability (Figure 4c ).
Apoptosis and necrosis in activated MU after collapse of the DW m . After 12 h activation, cells were treated with oligomycin, bongkrekic acid or antimycin A and DC m and cell viability were assessed for 60 h using mitotracker red chloromethyl-X-rosamine (CMXRos) and annexin-V staining and flow cytometry analysis. None of the drugs had any effect on the viability of control MF (Figure 5b) . In activated MF, with no drug treatment, there was a progressive apoptotic cell death (Figures 5a-d) . Treatment of activated MF with oligomycin increased the number of apoptotic cells in a time-dependent manner, whereas antimycin A had no effect. In activated þ SEITU-treated MF, with no drug treatment, approximately 90% of the cells were viable (mitotracker red positive, Figure 5b ). However, treatment of these cells with oligomycin or antimycin A resulted in a progressive increase in both apoptosis and necrosis ( Figures  5a, d and e) .
MF activated for 12 h and transferred to medium with galactose as the sole carbohydrate source died rapidly by necrosis (approximately 85% of cells were annexin-V negative and propidium iodide (PI) positive at 8 h after transfer, not shown). Activated þ SEITU-treated MF incubated in galactose medium died slowly by a combination of apoptosis and necrosis, and hence approximately 49% of cells were annexin-V and PI positive (apoptotic) and 16% were annexin-V negative and PI positive (necrotic) at 72 h (not shown).
Role of caspases in apoptosis of activated MU after collapse of DW m . Apoptosis can be triggered by extrinsic (caspase 8-mediated) and/or intrinsic (caspase 9-mediated) pathways, both of which can lead to activation of caspase 3 and result in the degradation of cellular proteins. MF activation led to a slight increase in the enzymatic activities of caspases 3, 8 and 9. Treatment of 12 h activated MF with oligomycin to collapse the DC m triggered a rapid and pronounced activation of caspases 3 and 9, but not of caspase 8 (Figures 6a-c) . A similar effect was obtained using bongkrekic acid (not shown). Antimycin A treatment, which had no effect on the DC m of activated MF, did not increase their caspase activity. There was little caspase activity in 12 h activated þ SEITU-treated MF; however, treatment with either oligomycin or antimycin A resulted in a delayed and gradual activation of caspases 3, 8 and 9 (Figures 6d-f) . In activated MF that were treated with oligomycin, the activation of caspases coincided with translocation of the pro-apoptotic Bcl-2 protein Bax to the mitochondria and the release of cytochrome c to the cytosol within 6 h of addition of oligomycin (Figures 6g and h ). In the activated þ SEITU treated MF, however, this happened to a lesser extent and after a long delay (Figure 6h) . Activated MF incubated in galactose medium died by necrosis and there was no significant activation of any of the caspases analysed (not shown). In contrast, in activated þ SEITU-treated MF incubated in galactose medium, there was an approximately threefold activation of caspases 3 and 8, but no significant activation of caspase 9 at 72 h (not shown).
Discussion
We have previously shown that in murine MF activated with IFN-g and LPS, respiration is completely inhibited by NO 
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Mitochondria utilize glycolytic ATP to prevent apoptosis A Garedew et al within 12 h and that this inhibition can be prevented by blocking iNOS activity with SEITU. Despite inhibition of respiration, activated MF maintain high cell viability by switching to glycolytic metabolism. 1 We now report that the DC m is maintained at a higher level in activated MF than in control MF, and that this protects the cells from apoptosis. In activated þ SEITU-treated MF the mitochondria are functional and the basal respiratory rate and DC m are significantly higher than those of control MF.
Treatment of activated MF with respiratory chain inhibitors (antimycin A, KCN or rotenone) had no effect on DC m , showing its independence of respiration in these cells. Such treatment did, however, reduce the DC m of control and of activated þ SEITU-treated MF. Treatment of activated MF with oligomycin or bongkrekic acid led to the collapse of their DC m , indicating its dependence on a reversed function of F o F 1 -ATP synthase and ANT. In contrast, treatment of cells with respiring mitochondria (i.e., control and activated plus SEITU-treated MF) with oligomycin or bongkrekic acid increased the DC m . Pre-treatment of control and of activated þ SEITU-treated MF with antimycin A induced a decrease in DC m in response to oligomycin or bongkrekic acid, similar to that in activated MF.
Our observations can be explained by the fact that the NOmediated inhibition of respiration in activated MF abolishes the translocation of H þ across complexes I, III and IV, leading to a transient drop in DC m . In response, the F 1 subunit of F o F 1 -ATP synthase starts hydrolyzing mitochondrial ATP and drives the Fo-rotor to pump H þ out of the matrix. 25 The resulting reduction in mitochondrial ATP/ADP ratio favours reversal of the ANT function. 26 The mitochondria of activated MF thus become consumers, rather than generators of ATP, further increasing the energetic demand of these cells.
Oligomycin or bongkrekic acid-induced inhibition of ATP hydrolysis by mitochondria of activated MF led to a 30% increase in the steady-state cellular [ATP] , suggesting that mitochondria use this quota of glycolytic ATP to maintain DC m . Treatment with antimycin A had no effect on the [ATP] of activated MF, as in these cells respiration was already inhibited by an NO-dependent mechanism. In contrast, treatment of control and of activated þ SEITU-treated MF with antimycin A or oligomycin led to an immediate fall in the cellular [ATP] . Although glycolysis was upregulated in the following 12 h in both cell groups, the steady-state cellular [ATP] was restored only in control MF after treatment with antimycin A. Thus, in activated þ SEITU-treated cells glycolysis cannot fully compensate for the antimycin A-or oligomycin-induced loss of mitochondrial function because of the higher energetic demand incurred by their activation. Similarly, in activated þ SEITU-treated MF mitochondrial ATP generation cannot compensate for the loss of glycolysis, as showed by the results of our experiments using galactose as the sole carbohydrate source in the medium. In the absence of glycolytic ATP generation, control MF were able to fulfil their energetic requirements by OXPHOS, whereas activated þ SEITU-treated MF gradually died, as their increased ATP demand could not be fulfilled by OXPHOS alone. Activated MF, whose mitochondria were already inhibited by NO, died by necrosis more rapidly when incubated in galactose medium. Activated MF underwent a basal level of apoptotic cell death that was associated with slight activation of caspases 3 and 8, showing that apoptosis in these cells was mainly triggered by the extrinsic pathway (for review see Kroemer et al. 11) . Apoptosis was increased dramatically by collapsing DC m with oligomycin or bongkrekic acid; this was associated with activation of caspases 3 and 9, indicating activation of a mitochondria-dependent apoptotic pathway.
Although SEITU protected activated MF from cell death, inhibition of respiration with oligomycin or antimycin A after 12 h activation induced significant cell death, and hence approximately 90% of these cells were dead after 48 h by a combination of apoptosis and necrosis. This was probably due to the inability of the glycolytic ATP supply to fulfil the increased energetic demand of these cells. Because of the absence of NO and hypoxia-inducible factor-1a (HIF-1a), the potent activators of glycolysis, the glycolysis of activated þ SEITU-treated MF is upregulated only by approximately 2.5-fold, compared with approximately sixfold upregulation in activated MF. 1 Inhibition of glycolytic ATP generation by incubating these cells in galactose medium also led to gradual cell death, indicating that the increased ATP demand has to be fulfilled by OXPHOS and glycolysis. Inhibition of either glycolysis or respiration thus compromises the ATP supply and survival of these cells.
The exact mechanism by which the collapse in DC m leads to the release of pro-apoptotic proteins into the cytosol and induces apoptosis is not yet clear. Furthermore, whether the collapse in DC m or the induction of apoptosis occurs first also remains a subject of controversy. 11 Apart from OXPHOS, one of the functions of DC m is to facilitate the import of nuclearencoded mitochondrial proteins, which are necessary for the maintenance of mitochondrial function and integrity. 27, 28 Thus, disruption of DC m may lead to loss of mitochondrial membrane integrity, release of pro-apoptotic proteins from the intermembrane space and subsequent activation of the caspase-mediated apoptotic pathway. In fact, it has been shown that the maintenance of DC m protects cells from death under apoptosis-inducing conditions. 29 Moreover, oligomycinmediated inhibition of F o F 1 -ATP synthase in activated Figure 6 Collapsing the DC m of activated MF leads to Bax translocation to the mitochondria, cytochrome c release and activation of caspases. Cells were activated in the presence or absence of SEITU for 12 h and then treated with oligomycin or antimycin A and samples were taken every 6 h to analyse the activities of caspase 3 (a, d), caspase 8 (b, e) and caspase 9 (c, f). Oligomycin and antimycin A treatment of control cells did not activate any of the caspases investigated (not shown). Treatment of activated MF with oligomycin led to an immediate activation of death caspases through the intrinsic pathway; antimycin A treatment, in contrast, had no effect (a-c). In activated þ SEITUtreated MF, both of these treatments resulted in a gradual, slight activation of caspases through both the intrinsic and extrinsic pathways (d-f). Mean ± S.D. of 3-5 measurements. After 12 h activation with or without SEITU, cells were treated with oligomycin and incubated for a further 6 and 18 h and then harvested for the separation of cytosolic and mitochondrial factions. The abundance of Bax and cytochrome c in both the cytosolic and mitochondrial fractions was evaluated by western blot (g, h). ATPase-b was used as a loading control for the mitochondrial fraction and also to check for possible contamination of the cytosolic fraction by mitochondria. a-Tubulin was used as a loading control for the cytosolic fraction. The blots are representatives of two experiments Cytosol Mitochondria Activated + SEITU MF leads to the collapse of DC m and accumulation of H þ in the matrix, probably resulting in cytosolic alkalinization and matrix acidification. It has been shown that alkalinization of the cytosol leads to conformational changes in the proapoptotic Bcl-2 protein Bax and results in the translocation of this protein to the outer mitochondrial membrane [30] [31] [32] [33] and subsequent release of pro-apoptotic intermembrane space proteins into the cytosol. 34, 35 Our results have shown that within 6 h of inhibition of F o F 1 -ATP synthase in activated MF, Bax is translocated to the mitochondria and cytochrome c is released into the cytosol, resulting in the activation of caspases.
In summary, we have shown that activated murine MF, in which mitochondria are inhibited, use a considerable proportion of their glycolytically generated ATP to maintain their DC m to prevent apoptotic cell death. This response suggests that activated MF, which are already engaged in defence, are also forced to defend themselves against their own mitochondria. However, it remains to be investigated whether diversion of energy for this purpose, which is also likely to occur in cells other than MF that express iNOS, favours or is detrimental to the successful outcome of an inflammatory reaction.
Materials and Methods
Reagents. The cell culture medium (Dulbecco's modified Eagle's medium, DMEM) supplemented with 4.5 g/l D-glucose, 2 mM L-glutamine (4 mM final) and 25 mM HEPES, penicillin, streptomycin and L-glutamine were from Invitrogen (Paisley, UK). Glucose-free DMEM was also obtained from Invitrogen, as were the potentiometric dye TMRM, the nuclear stain Hoechst 33342, the dead-cell nuclear stain PI, Vybrant Apoptosis Assay Kit containing annexin-V conjugated to the greenfluorescent dye Alexa Fluor488 for labelling apoptotic cells and MitoTracker Red CMXRos for labelling polarized mitochondria and ApoTarget colorimetric caspase assay sampler kit (for caspases 3, 8 and 9). Annexin V-conjugated to the green fluorescence dye fluorescein isothiocyanate (FITC) was from Biovision Inc (Mountain View, CA, USA). LPS of the bacterial strain Staphylococcus typhosa 0901 was from Difco (Surrey, UK), and murine IFNg was from Insight Biotech (Wembley, UK). The lactate oxidase-based lactate assay kit was from Trinity Biotech (Bray, Ireland), the luciferase-based ATP assay kit ATPlite was from Perkin Elmer (Waltham, MA, USA). All other reagents were from Sigma-Aldrich (Dorset, UK).
Cell culture, activation and preparation of macrophages. The murine MF cell line J774.Al (ATCC TIB 67) was maintained in suspension in stirrer bottles (Techne, Burlington, NJ, USA) in DMEM supplemented with 10% FCS, 100 units/ml penicillin and 100 mg/ml streptomycin. The cell density was kept at p1 Â 10 6 cells/ml to maintain viability at X98%. Cells were activated by resuspending them in stirrer bottles at a density of 0.5-0.8 Â 10 6 cells/ml in fresh medium containing 10 U/ml murine IFN-g and 10 ng/ml LPS. In one group, the activity of iNOS was inhibited by administration of 500 mM SEITU at the same time as IFN-g and LPS to distinguish the NO-dependent and NO-independent components of inflammation. In some experiments, oligomycin (2 mg/ml), bongkrekic acid (10 mM) or antimycin A (1 mM) was added 12 h after activation with IFN-g and LPS and cells were incubated further. For experiments that involve incubation of activated cells in glucose-free medium, after 12 h of activation cells were spun down and resuspended in glucose-free DMEM supplemented with 20 mM galactose, 4 mM L-glutamine, 2 mM pyruvate, 10% FCS, 100 units/ml penicillin, 100 mg/ml streptomycin and the corresponding treatments. The viability of activated cells incubated in galactose medium was determined every 2 h by the Trypan blue exclusion method.
As activated MF have a high glycolytic metabolism, we preserved optimal cell viability by changing the medium every 24 h to avoid nutrient depletion and medium acidification. For lactate and nitrite determination, 1 ml aliquot of the cell suspension was taken immediately after changing the medium and after 24 h, spun down and the supernatant was stored at 41C until analysis.
Respirometry measurements and biochemical assays. The respiration of activated cells was measured by taking a cell suspension of approximately 3 Â 10 6 cells from each treatment group at 12 and 24 h after activation and every 24 h thereafter. The cells were spun down, resuspended at 2 Â 10 6 cells/ml in fresh medium and used in respirometry experiments after cell counting and viability determination. Intact cell respirometry, lactate, nitrite and ATP assays were performed as described previously. 1 Confocal imaging and determination of mitochondrial membrane potential. A suspension of activated MF was removed from the stirrer bottles and seeded at a density of 0.1 Â 10 6 cells/0.8 cm 2 growth area of a chambered coverglass (Lab-Tek, Nunc, Langenselbold, Germany ) and incubated for 12 h before confocal imaging. The medium was aspirated, the cells were rinsed with Dulbecco's phosphate-buffered saline (DPBS), 200 ml annexin-V binding buffer containing 10 ml annexin V-FITC þ 2 mg/ml Hoechst 33342 þ 20 nM TMRM was added and cells were incubated for 15 min in the dark. Confocal microscopic images were taken with the UltraVIEW ERS Live Cell confocal Microscope (Perkin Elmer) with a Â 63 oil immersion objective. The cells were kept at 371C during the entire imaging period by a thermostatic chamber encasing the stage of the microscope. Data acquisition and further fluorescence analysis were carried out using UltraVIEW software. Whole cell fluorescence was analysed by marking individual cells in the field. Background fluorescence of a region without cells/cell debris was subtracted from the fluorescence values.
The role of the different respiratory chain complexes in maintaining DC m of activated and control MF was evaluated 72 h after activation by inhibiting the respiratory chain complexes I, III and IV with 1 mM rotenone, 1 mM antimycin A and 500 mM KCN, respectively, in separate experiments. In addition, mitochondrial complex V and ANT were inhibited with 2 mg/ml oligomycin and 10 mM bongkrekic acid, respectively. In some experiments, as an alternative to oligomycin (an inhibitor of the F o subunit of F o F 1 -ATP synthase) and bongkrekic acid (an inhibitor of ANT in its closed configuration) we also used 10 mM aurovertin B (an inhibitor of the F 1 subunit of F o F 1 -ATP synthase), and 500 mM atractyloside (an inhibitor of ANT in its open configuration).
The kinetics of action of the various inhibitors on DC m were studied by recording the TMRM fluorescence in time-lapse experiments. In brief, the steady-state TMRM fluorescence was recorded for 60 s to obtain a stable fluorescence signal. Subsequently antimycin A was added and the signal was recorded for approximately 100 s until a relatively stable signal was obtained. Oligomycin or bongkrekic acid was added and the signal was recorded for approximately 180 s. The DC m was finally collapsed completely with 25 mM FCCP. The FCCP concentration used here was approximately fivefold higher than that used to obtain maximal respiration, to ensure that the DC m was completely collapsed. To evaluate the roles of F o F 1 -ATP synthase and ANT on DC m of activated MF without previous addition of other mitochondrial inhibitors, oligomycin or bongkrekic acid was added after recording the steady-state TMRM signal for 60 s, and the fluorescence was recorded for a further 150 s.
Flow cytometry analysis of mitochondrial membrane potential and cell death. Activated MF were stained with the required fluorochromes and prepared for flow cytometry according to the manufacturer's recommendations. In brief, approximately 1 Â 10 6 cells were removed from the stirrer bottles at different time points after activation, spun down and resuspended in 1 ml fresh medium containing 40 nM mitotracker red CMXRos, and incubated at 371C for 30 min. Cells were then spun down, washed once with 10 ml DPBS and resuspended in 100 ml annexin-V binding buffer that contained 5 ml annexin V-Alexa Fluor488. They were then incubated at room temperature, in the dark, for 15 min and diluted with 400 ml annexin-V binding buffer before measurement. Apoptotic and necrotic control cells were obtained after treatment of control MF with 1 mM staurosporine and 2 mM H 2 O 2 , respectively, for 4 h.
Analysis of the stained cells was carried out with a dual laser flow cytometer (FACSCalibur, Becton Dickinson, San Jose, CA, USA) and data were acquired with CELLQUEST software. Single fluorochrome-labelled cells were used to correct for the spectral overlap between the green and red fluorescence. Furthermore, cell size and granularity data were acquired using the forward (FSC) and side light scatter (SSC) filters, respectively. For each sample, 1 Â 10 4 cells were analysed.
Caspase assay. Enzymatic activity of cysteine-aspartic acid proteases (caspases) in the cytosolic extracts of activated cells was determined spectrophotometrically by measuring the absorbance of free para-nitroaniline (pNA) as described by Talanian et al. 36 Samples for caspase assay were collected by removing 20 ml cell suspension immediately after oligomycin/antimycin A treatment and every 6 h thereafter. Cells were spun down, washed once with DPBS, resuspended in 500 ml chilled cell lysis buffer and incubated on ice (10 min) for complete cell lysis. After centrifugation (10 000 Â g, 2 min), the supernatant was stored at À201C until analysis.
Caspase assays were performed according to the manufacturer's recommendation (Invitrogen). In brief, protein concentration in the cytosolic extract was determined using the bicinchoninic acid protein assay (BCA assay, Pierce, Rockford, IL, USA) and 200 mg protein was used for the assay, in triplicate, in a 96-well microplate using 400 mM caspase substrate. The reaction mixture was incubated for 2 h at 371C and the absorbance of free pNA was measured at 405 nm. The reaction mixture with the corresponding caspase substrates was used as a blank. All samples were assayed with the substrates for caspases 3, 8 and 9.
Cell fractionation and detection of mitochondrial proteins. J774.A1 MF were grown in a suspension culture to approx. 0.8 Â 10 6 cells/ml in four 500 ml stirrer bottles (Techne). Medium in the three bottles was renewed by spinning down cells and resuspending in a new medium 2 h before beginning the treatment. The cells in the fourth bottle were spun down and used for cytosol/mitochondrial fractionation of control cells. Cells were activated by adding 10 U/ml IFN-g and 10 ng/ml LPS and incubated for 12 h. Cells in one bottle (12 h activation) were harvested by spinning down and those in the other two bottles were treated with 2 mg/ml oligomycin and incubated for a further 6 h (18 h activation) and 18 h (30 h activation) and harvested accordingly. The same experimental setup was repeated with the activated þ SEITU-treated cells. The cell pellets were lysed in isotonic buffer (70 mM sucrose, 200 mM mannitol, 1 mM EGTA, 10 mM Hepes, pH 7.4) supplemented with protease inhibitor cocktail (Roche, Basel, Switzerland) by Dounce homogenization. Unbroken cells, nuclei and heavy membrane particles were sedimented by spinning at 1000 Â g and discarded. The supernatant, containing both the mitochondrial and cytosolic fractions, was spun at 12 000 Â g for 20 min to pellet the mitochondrial fraction. The supernatant from this high-speed centrifugation (the cytosolic fraction) was stored at À801C until needed. The pellet (mitochondrial fraction) was washed once with isotonic buffer and finally resuspended in RIPA lysis buffer (50 mM Tris-HCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.4) supplemented with a protease inhibitor cocktail (Roche). These cytosolic and mitochondrial fractions were used to determine translocation of the pro-apoptotic Bcl-2 protein Bax into the mitochondria and efflux of cytochrome c into the cytosol after inhibiting F o F 1 -ATP synthase with oligomycin.
Protein electrophoresis and western blotting. Protein concentration in the different samples was determined using the BCA Protein Assay Reagent. Sample aliquots were mixed with Laemmli buffer, boiled for 10 min, and 25 mg total protein was fractionated using a precast 4-15% gradient SDS-PAGE gel electrophoresis (Bio-Rad, Hemel Hempstead, UK). Proteins were transferred to Hybond-P (PVDF) membranes (GE Healthcare, Amersham, UK) and subjected to immunoblot assays using mouse monoclonal antibodies against ATPase-b (Invitrogen), cytochrome c (BD-Pharmingen, San Jose, CA, USA), Bax (SigmaAldrich), a-tubulin (Abcam, Cambridge, UK) and horseradish peroxidaseconjugated goat antibody against mouse IgG (Dako, Glostrup, Denmark) at 1 : 2000 dilutions. The chemiluminescence signal was developed using ECL Plus western blot detection reagent (GE Healthcare).
Statistical analysis. Results are presented as mean±S.D. Statistical significance tests were performed using paired sample t-test, or one-way ANOVA and the Tukey's post hoc test, as appropriate, using OriginPro 8.0 (Northampton, MA, USA). Pp0.05 was considered to be significant.
